Biotech is booming... $XBI closed at ~$170
With today's surge, we're within striking distance of the $XBI All Time High of $174.79, reached in Feb 2021 during the pandemic-era biotech bubble.
Funnily enough, $MRNA was trading at ~$175/share back then (Feb 2021) and popped
It was great to sit down with @KymeraTx co-founder @LifeSciVC and revisit our early days, from the science that brought us together to the early decisions that still shape how we are building the company today. Ten years later, I’m proud of how far we’ve come and even more
Make US INDs Great Again - What will and will not work to regain US strength in phase 1 clinical trials
Great new blog post from @AlexHarding7 exploring the right solutions for US regulatory approaches to early clinical development
New blog: "Evolving Drug Discovery: AI, Infrastructure, and the Speed of Learning"
Great perspective from @AbbasRKazimi, CEO of Nimbus Therapeutics - a company that's been at the forefront of deploying computational technologies to discover and develop new medicines for almost
article on biotech innovation for fortune mag's US 250th anniversary series. the next decade is going to be amazing, don't miss it. the challenge will be to navigate an affordability crisis in hospitals and services without breaking our drug innovation engine.
